Sector: MedicalAntares Pharma, Inc. (AMEX: AIS)
Headlines
- Antares Pharma Enters into License and Asset Purchase Agreements with Ferring
Nov 11, 2009 08:01 AM | AIS
- Antares Pharma Reports Third Quarter 2009 Financial and Operating Results
Nov 09, 2009 04:05 PM | AIS, TEVA
- Antares Pharma to Present at the Merriman Investor Summit 2009
Nov 03, 2009 04:05 PM | AIS, TEVA
- Antares Pharma to Host Third Quarter 2009 Earnings Call
Nov 02, 2009 04:49 PM | AAPL, AIS
- Antares Pharma to Present at the 20th Annual Oppenheimer Healthcare Conference
Oct 27, 2009 05:05 PM | AIS, TEVA
- BioMed News Bytes: Angiotech, BioSante, HGSI
Oct 20, 2009 11:55 AM | AIS, ANPI, GSK, HGSI, SLE
- RidgewaterEquity.com Free Fundamental Sector & Market Research on AIS, AMG, WAT, ALK, ALTU and ACXM
Oct 08, 2009 05:31 AM | AIS, ALK, ALTU, AMG, WAT
- Antares Pharma, Inc. to Present at Rodman & Renshaw 11th Annual Healthcare Conference
Sep 03, 2009 08:00 AM | AIS
- Antares Pharma Announces Launch of Tjet Needle-Free Injector System by Marketing Partner Teva
Aug 25, 2009 08:00 AM | AIS, TEVA
- Antares Pharma Welcomes Eamonn P. Hobbs to Board of Directors
Aug 12, 2009 12:18 PM | AIS, DCTH
- AIS expects to beat profit forecasts
Nov 17, 2009 05:53 PM | AIS
- All Bets Are Off on Date for 3G Bids: Operators Say Price Could Be Cut More
Oct 26, 2009 11:52 AM | AIS, CAT, TELN, TOT
- DTAC: 3G Delays Hit Confidence
Oct 17, 2009 02:51 PM | AIS, CAT, TOT
- True Confirms 3G Readiness
Oct 16, 2009 05:52 PM | AIS, CP, TELN
- UW Gets Grant for Eastern Shoshone Database
Oct 14, 2009 01:55 PM | AIS
- Baht, Oil and Map Ta Phut Are Concerns
Oct 09, 2009 05:51 PM | AIS
- AIS: No Problem With 3G Terms: 'Delay Won't Help TOT and CAT'
Oct 09, 2009 04:52 PM | AIS, CAT, TELN, TOT
- PM Calls for 3G Licensing Fairness: Thai Firms Seen As Disadvantaged
Oct 06, 2009 09:50 AM | AIS, CAT, TOT
- Operators Could Face Costs of B10 Billion for 3G Licences
Sep 11, 2009 11:54 AM | AIS, CAT, TOT
- Southeast in Rebranding Drive
Sep 10, 2009 01:53 PM | AIS, IBM
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on GET, JAG, GSX, RTK, MJN and AIS
Oct 20, 2009 08:13 AM | AIS, GET, GSX, RTK
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on AIS, AMG, WAT, ALK, ALTU and ACXM
Oct 08, 2009 06:10 AM | ACXM, AIS, ALK, ALTU, AMG, WAT
- Antares Pharma Regains NYSE Amex Listing Compliance
Aug 14, 2009 10:18 AM | AIS
- Antares Pharma Reports Second Quarter 2009 Financial and Operating Results
Aug 13, 2009 08:00 AM | AIS, TEVA
- Antares Pharma to Host Second Quarter 2009 Earnings Call
Aug 04, 2009 12:26 PM | AIS
- CORRECTING and REPLACING Antares Pharma, Inc. To Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference
Aug 03, 2009 02:13 PM | AIS
- Antares Pharma Receives Payment from Teva for Commercial Development of Vibex™ Auto-Injector Product
Jul 30, 2009 08:25 AM | AIS
- Antares Pharma Announces Closing of Securities Offering
Jul 29, 2009 05:36 PM | AIS
- Antares Pharma, Inc. To Present At BMO Capital Markets 9th Annual Focus on Healthcare Conference
Jul 28, 2009 10:27 AM | AIS
- Antares Pharma Announces Pricing of Securities Offering
Jul 24, 2009 09:54 AM | AIS, COWN
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: Wotton Paul K (10K)
Nov 13, 2009 03:34 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: SHROTRIYA RAJESH C (10K)
Nov 13, 2009 03:33 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: JACOB LEONARD S (10K)
Nov 13, 2009 03:31 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: HOBBS EAMONN P (10K)
Nov 13, 2009 03:30 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: GUETH ANTON (10K)
Nov 13, 2009 03:28 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: GONELLA JACQUES (10K)
Nov 13, 2009 03:27 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: GARRITY THOMAS J (10K)
Nov 13, 2009 03:25 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: CARRARA DARIO (10K)
Nov 13, 2009 03:24 PM
- Form 4 ANTARES PHARMA, INC. For: Nov 12 Filed by: APPLE ROBERT F (10K)
Nov 13, 2009 03:21 PM
- Form 4 ANTARES PHARMA, INC. For: Aug 12 Filed by: HOBBS EAMONN P (10K)
Aug 14, 2009 07:18 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
AIS
|
Compare to S&P
|
| YTD |
191.89 %
|
141.11 %
|
| 4 Weeks |
-12.90 %
|
-13.36 %
|
| 12 Weeks |
12.50 %
|
5.57 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -33.33 %
|
|
EPS Growth in Last Year: 20.00 %
|
|
Sales Growth in Last Quarter: 22.80 %
|
|
Sales Growth in Last Quarter: 47.05 %
|
|
